Journal issue - WANFANG MED ONLINE

Contact US | Chinese

You Position: Home > Journal issue

Chinese Journal of Nuclear Medicine

Issue 4, 2021

Items 1-5 of 9

«Preious | of 2 | Next»

1

Analysis of curative effect after initial 131I treatment of familial differentiated thyroid cancer

Chinese Journal of Nuclear Medicine and Molecular Imaging, Volume 41, Issue 4,2021, Pages 201-206, doi:10.3760/cma.j.cn321828-20210201-00019

2

Preliminary study of 131I adjuvant therapy in BRAF V600E mutant patients with non-distant metastatic papillary thyroid cancer

Chinese Journal of Nuclear Medicine and Molecular Imaging, Volume 41, Issue 4,2021, Pages 212-217, doi:10.3760/cma.j.cn321828-20210202-00026

3

Correlation of IDO-1, LAG-3 and TIM-3 with clinicopathological features and prognosis of differentiated thyroid cancer

Chinese Journal of Nuclear Medicine and Molecular Imaging, Volume 41, Issue 4,2021, Pages 196-200, doi:10.3760/cma.j.cn321828-20200609-00227

4

Precision treatment of differentiated thyroid cancer: pan-radioiodine therapy management based on biomarker atlas

Chinese Journal of Nuclear Medicine and Molecular Imaging, Volume 41, Issue 4,2021, Pages 193-195, doi:10.3760/cma.j.cn321828-20210301-00048

5

《中华核医学与分子影像杂志》2021年第4期导读

Chinese Journal of Nuclear Medicine and Molecular Imaging, Volume 41, Issue 4,2021, Pages F01, doi:10.3760/cma.j.issn.2095-2848.2021.04.000

Items 1-5 of 9

«Preious | of 2 | Next»

WanfangData CO.,Ltd All Rights Reserved
About WanfangData | Contact US
Healthcare Department, Fuxing Road NO.15, Haidian District Beijing, 100038 P.R.China
Tel:+86-010-58882616 Fax:+86-010-58882615 Email:yiyao@wanfangdata.com.cn